Diltiazem Dosing for Rate Control in Atrial Fibrillation
For acute rate control in atrial fibrillation, administer diltiazem 0.25 mg/kg IV bolus over 2 minutes (typically 20 mg for average-weight patients), followed by a second bolus of 0.35 mg/kg (typically 25 mg) after 15 minutes if needed, then initiate continuous infusion at 10 mg/hour, titrating up to 15 mg/hour as needed. 1, 2
Initial IV Bolus Dosing
First bolus: Administer 0.25 mg/kg actual body weight IV over 2 minutes 1, 2
Second bolus (if inadequate response): After 15 minutes, administer 0.35 mg/kg actual body weight IV over 2 minutes 1, 2
Low-dose alternative: Evidence suggests that doses ≤0.2 mg/kg may be equally effective while reducing hypotension risk from 35% to 18% compared to standard dosing 3
- However, doses ≥0.13 mg/kg achieve heart rate control significantly faster (169 minutes vs 318 minutes) without increased hypotension 4
Continuous IV Infusion
Initial infusion rate: Start at 10 mg/hour immediately following the bolus dose 1, 2
- Some patients may maintain response at 5 mg/hour 2
Titration: Increase in 5 mg/hour increments up to a maximum of 15 mg/hour as needed for further heart rate reduction 1, 2
Duration: Maintain infusion for up to 24 hours maximum 2
- Infusion durations exceeding 24 hours and rates exceeding 15 mg/hour have not been studied and are not recommended 2
Pharmacokinetic considerations: Diltiazem exhibits dose-dependent, non-linear pharmacokinetics with decreased systemic clearance at higher infusion rates 5
Target Heart Rate Goals
- Lenient control: <110 bpm at rest 6, 1
- Strict control: <80 bpm at rest 6, 1
- The choice between lenient versus strict control depends on symptom burden and patient tolerance 6
Transition to Oral Maintenance Therapy
Immediate-release formulation: 120-360 mg daily in divided doses 1
Extended-release formulation: 180-360 mg once daily 1
Critical Contraindications (Must Screen Before Administration)
Heart failure with reduced ejection fraction (LVEF ≤40%): Absolute contraindication due to negative inotropic effects 1
- Use digoxin or amiodarone instead in these patients 1
Pre-excited atrial fibrillation (Wolff-Parkinson-White syndrome): Absolute contraindication as diltiazem can accelerate conduction through accessory pathways 6, 1
Severe hypotension: Contraindicated 1
Second or third-degree AV block without pacemaker: Contraindicated 1
Decompensated heart failure: Contraindicated 6
Monitoring Requirements
- Continuous monitoring during administration: Heart rate, blood pressure, and symptoms 6, 1
- Expected adverse effects:
Clinical Pearls and Pitfalls
Weight-based dosing is essential: Patients with low body weights should be dosed on a mg/kg basis rather than using fixed doses 2
Combination with beta-blockers: Use with extreme caution due to additive negative inotropic and chronotropic effects 1
Plasma concentration-response relationship: Plasma diltiazem concentrations of 79,172, and 294 ng/mL are required to produce 20%, 30%, and 40% reductions in heart rate, respectively 5
Class I recommendation: Diltiazem carries the highest level of evidence (Class I, Level B) for acute rate control in atrial fibrillation 1